Christine Nikolic
Adult Health · Mesa, AZNPI 1760482574
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $27.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$646
- Merck$528
- Impulse Dynamics (USA) Inc.$423
- Kestra Medical Technology Services, Inc.$319
- Boston Scientific$269
- Abbott$266
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,73395%
- Education$1734%
- Other$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 34 | $646 |
| Merck | 23 | $528 |
| Impulse Dynamics (USA) Inc. | 4 | $423 |
| Kestra Medical Technology Services, Inc. | 15 | $319 |
| Boston Scientific | 3 | $269 |
| Abbott | 7 | $266 |
| Medtronic | 2 | $229 |
| Boehringer Ingelheim | 9 | $185 |
| Sanofi-aventis U.S. LLC | 4 | $177 |
| Esperion Therapeutics, Inc. | 4 | $173 |
| Alnylam Pharmaceuticals Inc. | 3 | $134 |
| Pfizer | 7 | $113 |
| Amgen | 6 | $83 |
| Actelion Pharmaceuticals US, Inc. | 2 | $57 |
| Novo Nordisk | 2 | $41 |
| Astellas Pharma US Inc | 2 | $39 |
| Baxter Healthcare | 1 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Bayer | 2 | $33 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Johnson & Johnson | 2 | $27 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Abiomed | 1 | $16 |
| Altathera Pharmaceuticals LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMIZER$828
- WATCHMAN FLX$246
- CARDIOMEMS$173
- SYMPLICITY G3$155
- VERQUVO$113
- AMVUTTRA$103
How this compares
$3,944 in reported general payments places this provider in the 90th percentile of 314 adult health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 590 | $554,684 |
| JardianceEmpagliflozin | 282 | $249,864 |
| EliquisApixaban | 186 | $226,162 |
| FarxigaDapagliflozin Propanediol | 215 | $156,681 |
| XareltoRivaroxaban | 59 | $63,605 |
| BrilintaTicagrelor | 39 | $23,081 |
| Metoprolol Succinate | 353 | $4,736 |
| Eplerenone | 34 | $3,150 |
| Spironolactone | 471 | $2,906 |
| Potassium Chloride | 147 | $2,857 |
| Hydralazine Hcl | 226 | $2,403 |
| Atorvastatin Calcium | 203 | $2,393 |
| Ranolazine ErRanolazine | 21 | $2,358 |
| Valsartan | 163 | $2,209 |
| Isosorbide Dinitrate | 46 | $1,987 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $646 | $554,684590 claims |
| Boehringer IngelheimJardiance | $185 | $249,864282 claims |
| PfizerEliquis | $113 | $226,162186 claims |
| Johnson & JohnsonXarelto | $27 | $63,60559 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 314 adult health providers in Arizona.
Other adult health in Mesa
- Amy KleinhansMesa$60K
- Shauna BinetteMesa$11K
- Mary Jo Stucky HeilMesa$4K
- Carla GutierrezMesa$3K
- Therese SargentPhoenix$307K
- Heather McCoyScottsdale$156K
- Jennifer MylodGlendale$131K
- Natalie WilsonPhoenix$94K
- Michelle TaylorGilbert$36K
- Sherry DentonScottsdale$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.